The new document represents the ACC’s first Concise Clinical Guidance; it was designed to be an easy-to-use reference for keeping track of a complicated topic.
Two of the world’s leading medtech companies have been collaborating to improve patient access to CGM technology. It now looks like Medtronic and Abbott could…
The world is in the throes of an AFib pandemic, one that could potentially get worse in the years ahead due to population growth, economic…
“MRI images provide a better view of the anatomy of the heart and the instruments used for treatment, but also of the changes made to…
Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients.
Reviewing data from more than 6,000 patients, researchers found little evidence of the “obesity paradox” observed elsewhere. Underweight TAVR patients, however, may face some significant…
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study,…
The devices are being recalled and discontinued after the FDA shared a series of concerns. This is a Class I recall, meaning using this system…
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study,…
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study,…
Society of Cardiovascular Angiography and Interventions President James Hermiller, Jr., MD, explains SCAI’s push for wider adoption of new, innovative cath lab radiation protection technology…
